Decipher Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2021 ,inter alia, to consider and approve The Un-Audited Financial Results (standalone and Consolidated) for the Quarter and Half Year ended 30th September, 2021 and the Report of the Auditors thereon. And any other matter with the permission of the Board.

pdf

Decipher Labs Ltd.

18 Oct 2021, 12:35PM

11.78

5.18%

Company Update

Decipher Labs Ltd - 524752 - Compliance Certificate With RTA

BSE India

Compliance Certificate with RTA for the Half year ended 30th September, 2021

pdf

Decipher Labs Ltd.

18 Oct 2021, 12:26PM

11.78

5.18%

Company Update

Decipher Labs Ltd - 524752 - Compliance - PCS Certificate Under 40(9)

BSE India

Compliance Certificate from PCS under 40(9)

pdf

Decipher Labs Ltd.

13 Oct 2021

11.78

5.18%

Company Update

Decipher Labs Ltd - 524752 - Shareholding for the Period Ended September 30, 2021

BSE India

Decipher Labs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here

Decipher Labs Ltd.

06 Oct 2021

11.78

5.18%

Company Update

Decipher Labs Ltd - 524752 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Compliance Certificate for the Quarter ended 30th September, 2021

pdf

Decipher Labs Ltd.

04 Oct 2021

11.78

5.18%

Company Update

Decipher Labs Ltd - 524752 - Statement Of Investor Complaints For The Quarter Ended September 2021

BSE India

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Kumar RaghavanDesignation :- Company Secretary and Compliance Officer

Is Combat Drugs Ltd. worth buying?

56 Votes:

Buy 64.29%

Sell 17.86%

Hold 17.86%